Watermark

BGB-3111-309

Recruiting

A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

Ask to Join

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-309

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2022-501147-32-00

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20230546

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? No

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? No

No Study Documents